Please login to the form below

Not currently logged in
Email:
Password:

basil insulin lispro

This page shows the latest basil insulin lispro news and features for those working in and with pharma, biotech and healthcare.

Lilly delays filing of Lantus rival on safety concerns

Lilly delays filing of Lantus rival on safety concerns

Eli Lilly has reined in plans to topple Sanofi's Lantus from the head of the long-acting insulin market after delaying regulatory filings for its insulin peglispro in the EU ... Lilly has said it will now file for approval of basil insulin lispro (BIL),

Latest news

More from news
Approximately 1 fully matching, plus 0 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Just::Health Communications

Just:: is a different kind of healthcare communications agency. Since 2006, we’ve been collaborating with clients around the world to...

Latest intelligence

World Pancreatic Cancer Day 2018: Combating misconceptions in pancreatic cancer
Patients diagnosed with pancreatic cancer face a dismal prognosis, with the disease having the lowest survival rate of all major cancers. In spite of this, pancreatic cancer research is chronically...
World Diabetes Day: Interaction and impact of diabetes on mental health
For World Diabetes Day on the 14th November 2018, Nisha Shahrukh - Medical Writer at Mednet Group has written an article depicting the impact diabetes has on mental health. Including...
EU
Innovation in merger control and the impact on the pharmaceutical sector
Is focusing on pipeline products enough to assess regulatory risks?...

Infographics